跳至主要内容
临床试验/NCT02639793
NCT02639793Unknown4 期

A Nationwide Multicenter Trial Assessing the Effects of Catheter Ablation on Burden of Atrial Fibrillation Recorded by Implantable Cardiac Monitor

Heikki Huikuri3 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
300
试验地点
3
主要终点
Free of atrial fibrillation

研究概览

简要总结

The study will assess the atrial fibrillation burden recorded By implantable loop recorder at 12 and 24 months compared to baseline. The patients with clinical indication fo catheter ablation of paroxysmal atrial fibrillation will be randomized to three techniques: manual radiofrequency ablation, radiofrequency ablation using remote magnet monitoring, and cryoablation.

详细描述

A total of 300 patients will be randomized to three different catheter ablation techniques (100 patients/group); radiofrequency ablation using remote magnet navigation, radiofrequency ablation using manual method, and cryoablation. A loop recorder (REVEAL) is implanted one month before the catheter ablation of paroxysmal atrial fibrillation and the effects of atrial fibrillation burden will be compared between the three methods at 12 and 24 months after ablation excluding the first three months´ blanking period.

The primary endpoints are:

  1. the proportion of patients remaining free from atrial fibrillation, atrial flutter or atrial tachycardia (> 2 minutes) recorded by the implantable cardiac monitor (Medtronic) at 24 months follow-up and
  2. total atrial fibrillation burden recorded by the loop recorder.

Other endpoints:

  1. Atrial fibrillation burden in 7 days Holter recording at 12 and 24 months compared to baseline,
  2. the time to first documented symptomatic and asymptomatic recurrence of atrial fibrillation
  3. prescription of antiarrhythmic drugs after the 3 months blanking period following the ablation
  4. re-ablation after the index ablation procedure,
  5. total procedural duration;
  6. total time of fluoroscopy and radiation dose;
  7. number and duration of cardiovascular hospitalization;
  8. quality of life questionnaires at 12 months and 24 month compared with baseline,
  9. cognitive function at 12 and 24 month compared with baseline,
  10. cost-efficacy of the different ablation techniques.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Any contraindication to catheter ablation

结局指标

主要结局

Free of atrial fibrillation

时间窗: 24 months

the proportion of patients remaining free from AF, atrial flutter (AFL) or atrial tachycardia (AT) (\> 2 minutes) recorded by the implantable cardiac monitor (ICM, Reveal, Medtronic Co.) at 24 months.

次要结局

  • Total AF burden(24 months)
  • Incidence of adverse events(24 months)

研究者

发起方
Heikki Huikuri
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Heikki Huikuri

Professor

University of Oulu

研究点 (3)

Loading locations...

相似试验